Literature DB >> 12414259

Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.

Darius Soonawala1, Tania Amin, Klaus P Ebmeier, J Douglas Steele, Nadine J Dougall, Jonathan Best, Octave Migneco, Flavio Nobili, Klemens Scheidhauer.   

Abstract

BACKGROUND: For a quantitative comparison of images obtained during (99m)Tc-hexamethylpropylene amine oxime (HMPAO) single-photon emission computed tomography (SPECT), brain activity values are usually normalized to a reference region. In studies of Alzheimer-type dementia (ATD), the cerebellum is often used as a reference region, assuming that it is spared any major pathological involvement. Statistical parametric mapping (SPM) may enhance the evaluation of SPECT scans in ATD patients. However, current SPM software only allows scaling to average whole brain activity (i.e., global normalization). The aim of this study was to develop an easily applied, objective, and reproducible method for determining average cerebellar tracer uptake so that images can be scaled specifically to cerebellar activity prior to the performance of SPM analysis. We also investigated whether cerebellar normalization increases the sensitivity and specificity of SPM analysis of ATD patients compared with global normalization.
METHODS: Image files were taken from a parallel study investigating the use of SPECT as a diagnostic tool for early onset of ATD. Two methods for determining cerebellar activity were developed: one manually, using templates, the other automated, using specified coordinates entered into a Matlab routine. Group comparison of ATD patients versus controls (= healthy volunteers and depressed patients) was performed on a voxel-by-voxel basis using SPM 96 on Windows 95. Receiver operator characteristics (ROC) were computed for 20 student raters examining patient and control scans with and without single-subject SPMs.
RESULTS: The reduction of cerebral blood flow in the group of ATD patients appeared 1.7 times greater in spatial extent when the tracer uptake was normalized to cerebellum rather than to average whole brain activity. Computing the reverse contrast (reductions in the control group compared with ATD patients) produced clusters of significance in globally normalized images which were not manifest after normalizing to cerebellum. This is consistent with the notion that the cerebellum is spared in ATD. Analysis of the area under the ROC curve showed that cerebellar-normalized SPM produced significantly improved accuracy over perfusion scans alone.
CONCLUSION: An easily applied, objective, reproducible method was developed for normalizing images to cerebellum prior to the performance of SPM analysis. Cerebellar normalization produced more extensive abnormalities in SPM analyses of ATD patients than global normalization. Furthermore, cerebellar normalization produced marginally more accurate diagnostic results in single-scan SPM analysis of ATD patients than did global normalization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414259     DOI: 10.1006/nimg.2002.1259

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  34 in total

1.  99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.

Authors:  Pierre Malick Koulibaly; Flavio Nobili; Octave Migneco; Paolo Vitali; Philippe H Robert; Nicola Girtler; Jacques Darcourt; Guido Rodriguez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-15       Impact factor: 9.236

2.  Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Authors:  Bich-Ngoc-Thanh Tang; Satoshi Minoshima; Jean George; Annie Robert; Christian Swine; Patrice Laloux; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

3.  Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease.

Authors:  G Rodriguez; S Morbelli; A Brugnolo; P Calvini; N Girtler; A Piccardo; N J Dougall; K P Ebmeier; J C Baron; F Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-02       Impact factor: 9.236

4.  Statistical parametric mapping and statistical probabilistic anatomical mapping analyses of basal/acetazolamide Tc-99m ECD brain SPECT for efficacy assessment of endovascular stent placement for middle cerebral artery stenosis.

Authors:  Tae-Hong Lee; Seong-Jang Kim; In-Ju Kim; Yong-Ki Kim; Dong-Soo Kim; Kyung-Pil Park
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

5.  Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain.

Authors:  Agostino Chiaravalloti; Anna Elisa Castellano; Maria Ricci; Gaetano Barbagallo; Pasqualina Sannino; Francesco Ursini; Georgios Karalis; Orazio Schillaci
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

6.  Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls.

Authors:  Dorit Merhof; Pawel J Markiewicz; Günther Platsch; Jerome Declerck; Markus Weih; Johannes Kornhuber; Torsten Kuwert; Julian C Matthews; Karl Herholz
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

7.  Caspase-cleaved glial fibrillary acidic protein within cerebellar white matter of the Alzheimer's disease brain.

Authors:  Troy T Rohn; Lindsey W Catlin; Wayne W Poon
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

8.  Initial mini-mental state and cerebral perfusion in Alzheimer's disease.

Authors:  T Ones; I Midi; F Dede; N Tuncer; T Y Erdil; O Onultan; S Ceylan; S Inanir; H T Turoglu
Journal:  Clin Neuroradiol       Date:  2012-01-03       Impact factor: 3.649

9.  Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease.

Authors:  Uma S Yezhuvath; Jinsoo Uh; Yamei Cheng; Kristin Martin-Cook; Myron Weiner; Ramon Diaz-Arrastia; Matthias van Osch; Hanzhang Lu
Journal:  Neurobiol Aging       Date:  2010-03-31       Impact factor: 4.673

10.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.